Stay updated on Epacadostat & Pembrolizumab in GIST Clinical Trial

Sign up to get notified when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Epacadostat & Pembrolizumab in GIST Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T19:44:55.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Minor site revision from v3.4.1 to v3.4.2 with no changes to the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T00:46:11.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 on the page. No study details or user-facing content appear to be affected.
    Difference
    0.1%
    Check dated 2026-02-05T00:28:01.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Show glossary option added; capitalization adjusted for labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the revision/version updated to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T21:26:23.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Only a behind-the-scenes revision update was made: Revision: v3.3.4 was added and Revision: v3.3.3 was removed, with no changes to study content, endpoints, eligibility, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:59:50.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Locations section added with Michigan and New York. Separate Michigan Locations and New York Locations subsections were removed, and the HHS Vulnerability Disclosure footer link was removed.
    Difference
    0.3%
    Check dated 2025-12-23T21:12:30.000Z thumbnail image

Stay in the know with updates to Epacadostat & Pembrolizumab in GIST Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.